The Federal Trade Commission and several states are taking the founder of Vyera Pharmaceuticals, Martin Shkreli, to trial. They are accusing the company of blocking generic versions of a life-saving drug.
Vyera Pharmaceuticals Founder Faces Trial for Monopoly
By NTD Newsroom
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.